PRELUDE THERAPEUTICS INC (PRLD)
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
lululemon Strengthens Presence in Mexico with E-Commerce Launch and Store Expansion Plan
Parsons Demand Response Technology to Optimize and Enable Los Angeles Department of Water & Power’s Operations and Strategic Plan
United Therapeutics Corporation Presents New Data Spanning Pulmonary Hypertension Treatment, Lung Donor Expansion, and Xenotransplantation at ISHLT 2026
No Questions Received From Shareholders Relating To The AGM To Be Held On 30 April 2026
Holdings of interested parties/officers as of 31.3.26
STLA INVESTOR NOTICE: Stellantis N.V. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
Holdings of interested parties/officers as of 31.3.26
JinkoSolar to Report First Quarter 2026 Results on April 29, 2026
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026